Exhibit 99.2
ESSA Pharma Inc.
(the “Company”)
Annual General Meeting of Shareholders
(the “Meeting”)
June 25, 2019
REPORT OF VOTING RESULTS
(Pursuant to Section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations)
Common shares of the Company (the“Common Shares”) | |
represented at the Meeting: | 4,021,133 |
Total issued and outstanding Common Shares as at the record | |
date for the meeting: | 6,311,098 |
Percentage of issued and outstanding Common Shares represented: | 63.72% |
1. | Setting Number of Directors |
By ordinary resolution passed by show of hands, the number of directors for the ensuing year was set at seven.
2. | Election of Directors |
By ordinary resolution passed by ballot vote, the following seven nominees proposed by management were elected as directors of the Company to hold office until the next annual meeting of the shareholders of the Company (the “Shareholders”) or until their successors are elected or appointed:
Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld |
David R. Parkinson | 3,413,685 | 95.64% | 155,625 | 4.36% |
Richard M. Glickman | 3,420,645 | 95.83% | 148,665 | 4.17% |
Raymond Andersen | 3,413,685 | 95.64% | 155,625 | 4.36% |
Gary Sollis | 3,560,520 | 99.75% | 8,789 | 0.25% |
Franklin M. Berger | 3,415,107 | 95.68% | 154,202 | 4.32% |
Scott Requadt | 3,224,071 | 90.33% | 345,238 | 9.67% |
Otello Stempacchia | 3,224,062 | 90.33% | 345,248 | 9.67% |
3. | Appointment of Auditor |
By ordinary resolution passed by show of hands, Davidson & Company LLP, Chartered Professional Accountants, was appointed auditor of the Company for the ensuing year.
-2 - |
4. | Amendments to Stock Option Plan |
By ordinary resolution passed by ballot vote, an amendment to the Company’s stock option plan as set out in Schedule A to the Company’s management information circular dated May 27, 2019 and provided to the Shareholders in connection with the Meeting (the “Circular”) was authorized and approved:
Votes by Ballot | Votes For | % Votes For | Votes Against | % Votes Against |
By all shareholders | 3,211,009 | 89.96% | 358,300 | 10.04% |
5. | Amendments to Restricted Share Unit Plan |
By ordinary resolution passed by ballot vote, an amendment to the Company’s restricted share unit plan as set out in Schedule B to the Circular was authorized and approved:
Votes by Ballot | Votes For | % Votes For | Votes Against | % Votes Against |
By all shareholders | 3,207,835 | 89.87% | 361,474 | 10.13% |
By disinterested shareholders | 723,711 | 66.69% | 361,474 | 33.31% |
6. | Employee Stock Purchase Plan |
By ordinary resolution passed by show of hands, the Company’s employee stock purchase plan as set out in Schedule C to the Circular was authorized and approved:
Votes by Ballot | Votes For | % Votes For | Votes Against | % Votes Against |
By all shareholders | 3,568,042 | 99.96% | 1,267 | 0.04% |
No other non-routine business was transacted or voted upon at the Meeting.
Dated: June 25, 2019